Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

In its fourth quarter 2024 investor letter, The London Company SMID Cap Strategy emphasized stocks such as Bruker Corporation (NASDAQ:BRKR). Bruker Corporation (NASDAQ:BRKR) focuses on developing ...

DeutEx is now integrated into the Bruker proteomics ecosystem to support timsTOF, MRMS and MALDI-TOF systems. Dr. Petr Novák, the Head of Structural Biology and Cell Signaling in the Institute of ...

This JupyterNotebook-based code implements a Mass Spectrometry Imaging (MSI) visualiser tool that allows researchers to explore molecular distributions across various samples for MALDI and DESI images ...

Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 ... microbiology and infection diagnostics driven by both the MALDI Biotyper and the newly acquired ELITech Molecular ...

(3) Bruker Scientific Instruments (BSI) revenue reflects the sum of the BSI BioSpin, CALID and Nano Segments as presented in our Annual Report on Form 10-K for the year ended December 31 ...

Bruker exceeded both EPS and revenue forecasts for Q4 2024. The company reported a 14.6% year-over-year increase in quarterly revenue. Stock price decreased by 0.77% despite the earnings beat ...

Scientific instrument company Bruker (NASDAQ:BRKR ... The life sciences subsector specializing in research tools and consumables enables scientific discoveries across academia, biotechnology ...